PLA2G2D and skin squamous cell carcinoma: In conclusion, through integrating bioinformatics and experimental verification, we demonstrated that the metabolic molecule PLA2G2D was positively correlated with immune infiltration and patient prognosis in CSCC, suggesting that PLA2G2D could be a novel prognosis biomarker for CSCC patients.